(R-Smads) fall into two groups, each serving one branch bind DNA on their own? As it turns out, the affinity of Smads for their cognate sequence is too low to achieve unassisted binding to DNA ( expression of GDF5 in the joint region contributes to joint excluding the carboxy-terminal region. CBFA1 homozygous null mice lack both endochondral and intramemmorphogenesis (Storm and Kingsley, 1999). In addition, GDF5 accelerates the initial stages of chondrogenesis branous bones, display defects in chondrocyte maturation, and die minutes after birth due to the inability to such as mesenchymal condensation by increasing cell adhesion and later can increase chondrocyte proliferabreathe. CBFA1 heterozygous null mice show specific bone defects that phenocopy CCD patients, consistent tion (Francis-West et al., 1999) .
). p15, a member of the Inhibition of cell proliferation is central to the TGF␤ reInk4 family of cdk inhibitors, specifically inhibits the sponse in epithelial, endothelial, hematopoietic, neural, cyclin D-dependent kinases, cdk4 and cdk6, by binding and certain types of mesenchymal cells, and escape to the cdk subunit, inactivating the catalytic activity and from this response is a hallmark of many cancer cells.
preventing the assembly of new cyclin D-cdk complexes TGF␤ can induce antiproliferative gene responses at from latent pools. Cyclin D-cdk4/6 complexes function any point during the division cycle. However, these reearly in G1 and act as mitogen sensors. Their inhibition sponses are effective at inhibiting cell cycle progression by TGF␤ via p15 thus deprives the cell of this class of only during G1. Once a cell becomes committed to exe-G1 cdk activities. cuting DNA replication in late G1, the division cycle will Cyclin D-cdk4/6 complexes also support cell cycle proceed undeterred by TGF␤ until the cell enters G1 progression with a noncatalytic function, namely, the again following mitosis, at which point the cell cycle will sequestration of the cdk inhibitor p27Kip1 (henceforth arrest. In most cases this arrest is reversible, but in some p27 Figure 5A ). TGF␤ addition can also prevent the increase in cdk4 levels that occurs under the particular conditions of mitogen-deprived cell cultures replenished with serum; this effect occurs at the translational level, requires the 5ЈUTR of cdk4, and is p53 dependent (Ewen et al., 1995) . Another cdk inhibitory response to TGF␤ is the downregulation of cdc25A (Iavarone and Massagué , 1997) (Figure 5A) . The cdc25 family of tyrosine phosphatases removes inhibitory tyrosine phosphorylation from cdks. Cdc25A downregulation by TGF␤ in MCF-10A mammary epithelial cells leads to accumulation of tyrosine phosphorylation on cdk4 and cdk6 and subsequent inhibition of these kinases. A mutant form of cdk6 lacking the phosphorylatable tyrosine residue is resistant to inhibition by TGF␤ in these cells. This multiplicity of antiproliferative TGF␤ gene responses assures that growth inhibi- Given this, it should come as no surprise that various In the developing limb, early expression of GDF5 is both necessary and sufficient to stimulate cartilage developheritable developmental disorders in humans turn out to be caused by mutations in the TGF␤ system (Figure ment and inhibit joint marker expression, including GDF5 itself and Gli3, thus restricting joint formation later 6). In addition, abnormal TGF␤ signaling has also been implicated in widespread human disorders including fito the appropriate locations. Subsequently, a narrower expression of GDF5 in the joint region contributes to joint excluding the carboxy-terminal region. CBFA1 homozygous null mice lack both endochondral and intramemmorphogenesis . In addition, GDF5 accelerates the initial stages of chondrogenesis branous bones, display defects in chondrocyte maturation, and die minutes after birth due to the inability to such as mesenchymal condensation by increasing cell adhesion and later can increase chondrocyte proliferabreathe. CBFA1 heterozygous null mice show specific bone defects that phenocopy CCD patients, consistent tion (Francis-West et al., 1999) .
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